GENX — Genix Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- CA$3.55m
- CA$4.69m
- CA$0.01m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.031 | 0.697 | 0.139 | 0.009 | 0.012 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.004 | 0.008 | 0.005 | 0.017 | 0.001 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.04 | 0.716 | 0.188 | 0.24 | 0.216 |
Net Property, Plant And Equipment | 0 | — | 0.032 | 0.004 | 0 |
Net Intangible Assets | |||||
Total Assets | 0.04 | 5.35 | 4.77 | 4.25 | 0.223 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.082 | 0.35 | 0.744 | 1.05 | 1.36 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.082 | 0.49 | 0.755 | 1.05 | 1.36 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.042 | 4.86 | 4.01 | 3.2 | -1.14 |
Total Liabilities & Shareholders' Equity | 0.04 | 5.35 | 4.77 | 4.25 | 0.223 |
Total Common Shares Outstanding |